Accountable care organizations (ACOs) in the Medicare Shared Savings Program saved $2.4 billion in 2024, according to data released last week by the Centers for Medicare and Medicaid Services (CMS).

A few months ago a clinic executive pulled me aside at a conference. The executive knew some of the clinics we partnered with and said: “We tried an AI Voice Agent. It didn’t bring the results we ...

Two large, international healthcare investment firms announced their plans to merge on Wednesday. The partners — London-based GHO Capital and Singapore-based CBC Group — said the deal will combine $21 ...

Providers are voicing concern over HHS Secretary Robert F. Kennedy Jr.’s firing of the vice chairs of the U.S. Preventive Services Task Force (USPSTF). They say the move raises fresh questions about ...

The Trump administration’s crackdown on fraud, waste and abuse continues, with the Department of Justice last week launching a new effort targeting healthcare fraud. Experts think the new strike force ...

In a recent letter, a group of 48 employer and consumer organizations are calling on the Trump Administration to strengthen oversight of certified independent dispute resolution (IDR) entities, which ...

As hospitals brace for rising costs tied to President Donald Trump’s proposed tariffs, a new report from the American Hospital Association reveals that drugs and supplies are just part of the problem.

Nourish, a metabolic health clinic, announced Tuesday that it raised $100 million in Series C funding, which will help grow its clinical network. New York City-based Nourish has more than 10,000 ...

The clinical trial industry spent the better part of the last decade solving a proximity problem. If patients couldn’t — or wouldn’t — come to a trial site, technology would meet them where they were.

March has seen a slew of executive hires, exits and layoffs across the healthcare industry. For example, providers like Providence and Geisinger have appointed new C-suite leaders, and companies like ...

For biopharma companies, designing therapies with elderly patients in mind is no longer a nice-to-have — it’s a clear business imperative. As we all know, adults over 65 represent one of the ...